Under construction – not a live service
Sign in
Taking people in SwitzerlandNo phase

Tracks children in Switzerland with breathing, wheezing and cough problems

Follows children with recurrent wheeze, cough or breathing problems through routine care over time.

Plain-language title generated from the registry record
Registry title: Swiss Paediatric Airway Cohort

Key facts

Where
Aarau, Basel, Bern, Chur, Horgen, Lausanne, Lucerne, Sankt Gallen, Worb, and Zurich, SwitzerlandSee the 11 sites

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 0 and 16 years old?

Source: NCT03505216, who can take part

Where in Switzerland

  • Children's hospital AarauAarau, SwitzerlandNo longer taking part
  • University Children's Hospital Basel (UKBB)Basel, SwitzerlandTaking people
  • Institute of Social and Preventive MedicineBern, SwitzerlandTaking people
  • University Children's Hospital Bern, InselspitalBern, SwitzerlandTaking people
  • Children's Hospital ChurChur, SwitzerlandTaking people
  • Pulmonology clinic, HorgenHorgen, SwitzerlandTaking people
  • University Children's hospital Lausane, CHUVLausanne, SwitzerlandTaking people
  • Children's hospital LucerneLucerne, SwitzerlandTaking people
  • Children's hospital St. GallenSankt Gallen, SwitzerlandNo longer taking part
  • Pulmonology clinic, WorbWorb, SwitzerlandTaking people
  • University Children's Hospital ZurichZurich, SwitzerlandTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University of Bern
Trial code
NCT03505216
Record updated
21 April 2026
Original description
The Swiss Paediatric Airway Cohort (SPAC) is a national, prospective clinical cohort of children and adolescents who visit physicians in Switzerland for recurrent wheeze, cough, and exercise- or sleep-related respiratory problems. SPAC aims to answer important questions on clinical phenotypes, prognosis, diagnosis and treatment. SPAC is part of routine care, and only clinically indicated investigations are done. The comprehensive baseline assessment includes a detailed questionnaire to families, plus test results, diagnoses and treatments from hospital records. Follow-up is via monthly questionnaires the first 12 months and thereafter annual questionnaires to families, and data from follow-up visits.Read full original descriptionShow less

Swiss Paediatric Airway Cohort

The Swiss Paediatric Airway Cohort (SPAC) is a national, prospective clinical cohort of children and adolescents who visit physicians in Switzerland for recurrent wheeze, cough, and exercise- or sleep-related respiratory problems. SPAC aims to answer important questions on clinical phenotypes, prognosis, diagnosis and treatment. SPAC is part of routine care, and only clinically indicated investigations are done. The comprehensive baseline assessment includes a detailed questionnaire to families, plus test results, diagnoses and treatments from hospital records. Follow-up is via monthly questionnaires the first 12 months and thereafter annual questionnaires to families, and data from follow-up visits.

Currently, 4344 patients from 10 clinics and hospitals in Switzerland (Aarau, Basel, Bern, Chur, Horgen, Lausanne, Luzern, St. Gallen, Worb, Zurich) have been enrolled.

SPAC provides real-life data on children visiting the Swiss health care system for common respiratory problems. It will provide a research platform for health services research, and for nested clinical and transitional studies.

Publications and plain language summaries are listed on the study website: https://www.spac-study.ch/publikationen/

Inclusion: Children and adolescents aged 0-16 years; Resident in Switzerland; Seen in a paediatric pulmonary outpatient clinic due to respiratory problems; Parents and patients above age 14 must be able to sign an informed consent form.

Exclusion: Prior diagnosis of cystic fibrosis, primary ciliary dyskinesia, severe heart disease, oncological disease, neuromuscular disease or severe disability.

ClinicalTrials.gov NCT03505216